Recursion Pharmaceuticals (RXRX) has been drawing attention after recent trading, with the stock closing at $4.67. Investors are weighing this price against the company’s clinical pipeline and ongoing ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best debt-free penny stocks to buy right now. On December 17, JPMorgan upgraded Recursion Pharmaceuticals (NASDAQ:RXRX) to an Overweight ...

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

Nvidia's ( NVDA) CEO Jensen Huang said the company’s proposed $100B investment in OpenAI was “never a commitment” and that the AI chipmaker would consider any funding rounds “one at a time,” Bloomberg ...

This crowd-curated digital movement is one of the most pertinent and explicit reactions to our particular slice of dystopian ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Europe's low snow cover sets the stage for even higher gas burn Europe's appetite for natural gas could climb more steeply than expected this year after skimpy snow coverage across key mountainous ...

When researchers first observed the presence of circular RNAs in the 1970s, they were an inexplicable biological oddity — and they remained so for many years afterward. The field of RNA biology was in ...

For the vast majority of Earth’s existence, our planet functioned as the quintessential circular system. The Sun’s energy nourished trees into life, and once they fell, microorganisms broke them down ...

Just when investors were thinking they understood the AI Boom, the rules shifted again… Forget everything you thought you knew about the “Magnificent 7.” We’ve moved beyond the individual gladiators ...

Since Nvidia agreed last month to invest $100 billion in its customer OpenAI, investors and analysts who follow artificial intelligence have awakened to that industry’s circularity.